Tranexamic acid, identified by CAS NO. 1197 - 18 - 8, is a well - known synthetic derivative of the amino acid lysine. It has gained significant popularity in various fields, especially in the medical and cosmetic industries. As a reliable supplier of Tranexamic acid, I understand the importance of providing comprehensive information about its proper use and precautions. In this blog, I will delve into the key precautions that users should take when working with Tranexamic acid.
1. Medical Use Precautions
1.1 Contraindications
Tranexamic acid is contraindicated in patients with a history of thromboembolic events. This includes individuals who have suffered from deep vein thrombosis (DVT), pulmonary embolism (PE), or stroke. The drug works by inhibiting the breakdown of blood clots, and in these patients, it may increase the risk of further clot formation, potentially leading to life - threatening complications.
Patients with active intravascular clotting disorders, such as disseminated intravascular coagulation (DIC), should also avoid using Tranexamic acid. In DIC, the body's normal blood - clotting mechanism is disrupted, and the administration of Tranexamic acid may exacerbate the abnormal clotting process.
Pregnant and breastfeeding women should use Tranexamic acid with extreme caution. Although there is limited evidence suggesting potential harm to the fetus or infant, more research is needed. In many cases, the benefits of using the drug must be carefully weighed against the potential risks.
1.2 Drug Interactions
Tranexamic acid can interact with other medications. For example, it should not be used in combination with other antifibrinolytic agents, as this can significantly increase the risk of thrombosis. Drugs such as aminocaproic acid, which also work by inhibiting fibrinolysis, should be avoided when using Tranexamic acid.
It may also impact the effectiveness of oral contraceptives. Some studies have suggested that Tranexamic acid can interfere with the metabolism of hormonal contraceptives, potentially reducing their efficacy. Women using oral contraceptives should consult their healthcare providers before starting Tranexamic acid treatment.
1.3 Dosage and Administration
Proper dosage is crucial when using Tranexamic acid in medical settings. Overdosing can lead to an increased risk of side effects, while underdosing may not achieve the desired therapeutic effect. The dosage is usually determined based on the patient's age, weight, and the specific medical condition being treated.
In most cases, Tranexamic acid is administered orally, intravenously, or topically. When given intravenously, it should be infused slowly to minimize the risk of side effects such as nausea, vomiting, and hypotension. Healthcare providers should closely monitor patients during and after administration to ensure their safety.
2. Cosmetic Use Precautions
2.1 Skin Sensitivity
In the cosmetic industry, Tranexamic acid is often used for its skin - lightening and anti - inflammatory properties. However, some individuals may be sensitive to the compound. Before using any cosmetic product containing Tranexamic acid, it is recommended to perform a patch test on a small area of skin, such as the inner forearm. Leave the product on for 24 - 48 hours and observe for any signs of irritation, redness, itching, or swelling.
If a negative reaction occurs during the patch test, the product should not be used on a larger area of the skin. People with sensitive skin, eczema, or other skin conditions are at a higher risk of experiencing adverse reactions and should be especially cautious.
2.2 Concomitant Use with Other Cosmetic Ingredients
When formulating cosmetic products with Tranexamic acid, it is important to consider its compatibility with other ingredients. Some ingredients may interact with Tranexamic acid, potentially reducing its effectiveness or causing skin irritation. For example, strong acids or bases in a formulation may affect the stability of Tranexamic acid.
It is also important to note that combining Tranexamic acid with other skin - lightening agents, such as α-Arbutin;CAS NO.84380-01-8, Ascorbyl Palmitate;CAS NO.137-66-6, or Hydroxypinacolone Retinoate ; CAS NO.: 893412-73-2, may increase the risk of skin irritation. Therefore, careful consideration and testing should be done before formulating products with multiple active ingredients.
2.3 Storage and Shelf - Life
Cosmetic products containing Tranexamic acid should be stored properly to maintain their stability and effectiveness. They should be kept in a cool, dry place away from direct sunlight. High temperatures and humidity can degrade the compound, reducing its potency.
The shelf - life of these products should also be respected. Using expired products can lead to reduced efficacy and may even pose a risk to the skin. Always check the expiration date on the product label and discard any expired products.
3. General Precautions
3.1 Handling and Storage
When handling Tranexamic acid in a laboratory or industrial setting, appropriate safety measures should be taken. Wear protective clothing, gloves, and goggles to prevent skin and eye contact. In case of accidental contact, immediately rinse the affected area with plenty of water and seek medical advice if necessary.
Tranexamic acid should be stored in a tightly sealed container in a cool, dry place. It should be kept away from incompatible substances, such as strong oxidizing agents, to prevent chemical reactions.
3.2 Quality Control
As a supplier, I emphasize the importance of quality control. Ensure that the Tranexamic acid you purchase meets the required quality standards. Low - quality products may contain impurities that can increase the risk of side effects or reduce the effectiveness of the compound. Look for suppliers who provide detailed product specifications and have a good reputation for quality.
4. Conclusion
Tranexamic acid is a versatile compound with numerous applications in the medical and cosmetic fields. However, it is essential to use it with caution. Whether you are a healthcare provider, a cosmetic formulator, or an end - user, understanding the precautions associated with Tranexamic acid is crucial for ensuring its safe and effective use.
If you are interested in purchasing high - quality Tranexamic acid (CAS NO. 1197 - 18 - 8) or other related cosmetic raw materials such as Hesperetin 7-O-glucoside;CAS NO.31712-49-9 and Gotu Kola P.E.(80% Triterpenes) ; CAS NO.: 16830-15-2, feel free to contact us for more information and to start a procurement discussion.
References
- "Tranexamic acid: a review of its use in the treatment of heavy menstrual bleeding." Journal of Obstetrics and Gynaecology Canada.
- "Safety and efficacy of topical tranexamic acid for melasma treatment." Journal of Cosmetic Dermatology.
- Product monographs of Tranexamic acid from pharmaceutical companies.